Curative Biotechnology, Inc. (CUBT)
OTCMKTS · Delayed Price · Currency is USD
0.0089
-0.0003 (-3.26%)
Aug 1, 2025, 1:50 PM EDT
Curative Biotechnology Market Cap
Curative Biotechnology has a market cap or net worth of $9.42 million as of August 1, 2025. Its market cap has decreased by -40.41% in one year.
Market Cap
9.42M
Enterprise Value
12.31M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since February 22, 2008, Curative Biotechnology's market cap has decreased from 22.36M to 9.42M, a decrease of -57.87%. That is a compound annual growth rate of -4.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 9.32M | -20.81% |
| Dec 31, 2024 | 11.77M | -12.66% |
| Dec 29, 2023 | 13.47M | 17.84% |
| Dec 30, 2022 | 11.43M | -61.12% |
| Dec 31, 2021 | 29.41M | 201.64% |
| Dec 31, 2020 | 9.75M | 1,242.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 584.53M |
| Glass House Brands | 435.01M |
| Northwest Biotherapeutics | 372.10M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 341.59M |